Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Technology

  2.3.2 Market Size By Application

  2.3.3 Market Size By Product

  2.3.4 Market Size By Channel

 2.3.5 Market Size By End Use

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Test Type & Technology Architecture Metrics

4.1.1 Types of genetic tests – diagnostic testing, predictive & presymptomatic testing, carrier testing, prenatal & newborn screening, and pharmacogenomic testing

4.1.2 Direct-to-consumer (DTC) vs clinical laboratory-based testing models

4.1.3 Single-gene vs multi-gene panel testing

4.1.4 Whole exome sequencing (WES) vs whole genome sequencing (WGS)

4.1.5 Targeted sequencing vs genome-wide analysis

4.1.6 PCR-based vs next-generation sequencing (NGS) technologies

4.1.7 Microarray-based genotyping platforms

4.2 Sequencing & Analytical Performance Metrics

4.2.1 Sequencing accuracy and error rates

4.2.2 Read length and coverage depth performance

4.2.3 Turnaround time (TAT) for test results

4.2.4 Sensitivity and specificity in variant detection

4.2.5 Variant calling and annotation accuracy

4.2.6 Detection of rare and low-frequency mutations

4.2.7 Reproducibility and test consistency

4.3 Sample Type & Processing Metrics

4.3.1 Blood, saliva, buccal swab, and tissue sample utilization

4.3.2 DNA extraction and purification efficiency

4.3.3 Sample preparation time and workflow complexity

4.3.4 Sample stability and storage requirements

4.3.5 Non-invasive sample collection adoption

4.3.6 Sample contamination and quality control measures

4.3.7 Automation in sample processing

4.4 Clinical Application & Disease Area Metrics

4.4.1 Oncology and cancer genomics testing

4.4.2 Rare disease diagnosis and genetic disorder screening

4.4.3 Prenatal and reproductive health testing

4.4.4 Cardiovascular and metabolic disease risk assessment

4.4.5 Pharmacogenomics and personalized medicine

4.4.6 Infectious disease genomics and pathogen detection

4.4.7 Neurological and hereditary disease testing

5. Genetic Testing Market Segmental Analysis & Forecast, By Technology, 2022 – 2035, Value (USD Billion)

5.1 Introduction

 5.2 Next Generation Sequencing

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2035

 5.3 Array Technology

    5.4 PCR - based Testing

    5.5 FISH

    5.6 Others

6. Genetic Testing Market Segmental Analysis & Forecast, By Application, 2022 – 2035, Value (USD Billion)

    6.1 Introduction

 6.2 Ancestry & Ethnicity

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022 – 2035

 6.3 Traits Screening

    6.4 Genetic Disease Carrier Status

    6.5 New Baby Screening

    6.6 Health and Wellness - Predisposition/ Risk / Tendency

7. Genetic Testing Market Segmental Analysis & Forecast, By Product, 2022 – 2035, Value (USD Billion)

    7.1 Introduction

 7.2 Consumables

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022 – 2035

 7.3 Equipment

    7.4 Software & Services

8. Genetic Testing Market Segmental Analysis & Forecast, By Channel, 2022 – 2035, Value (USD Billion)

    8.1 Introduction

 8.2 Online

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022 – 2035

 8.3 Online

9. Genetic Testing Market Segmental Analysis & Forecast, By End Use, 2022 – 2035, Value (USD Billion)

    9.1 Introduction 

  9.2 Hospitals & Clinics

   9.2.1 Key Trends 

   9.2.2 Market Size & Forecast, 2022 – 2035 

  9.3 Diagnostic Laboratories

        9.4 Others

10. Genetic Testing Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)

 10.1 Introduction

 10.2 North America

  10.2.1 Key Trends

  10.2.2 Genetic Testing Market Size & Forecast, By Technology, 2022 – 2035

  10.2.3 Genetic Testing Market Size & Forecast, By Application, 2022 – 2035

  10.2.4 Genetic Testing Market Size & Forecast, By Product, 2022 – 2035

  10.2.5 Genetic Testing Market Size & Forecast, By Channel, 2022 – 2035

  10.2.6 Genetic Testing Market Size & Forecast, By End Use, 2022 – 2035

  10.2.7 Genetic Testing Market Size & Forecast, By Country, 2022 – 2035

   10.2.7.1 USA

   10.2.7.2 Canada

10.3 Europe

 10.3.1 Key Trends

 10.3.2 Genetic Testing Market Size & Forecast, By Technology, 2022 – 2035

 10.3.3 Genetic Testing Market Size & Forecast, By Application, 2022 – 2035

 10.3.4 Genetic Testing Market Size & Forecast, By Product, 2022 – 2035

 10.3.5 Genetic Testing Market Size & Forecast, By Channel, 2022 – 2035

 10.3.6 Genetic Testing Market Size & Forecast, By End Use, 2022 – 2035

 10.3.7 Genetic Testing Market Size & Forecast, By Country, 2022 – 2035

  10.3.7.1 Germany

  10.3.7.2 UK

  10.3.7.3 France

  10.3.7.4 Italy

  10.3.7.5 Spain

  10.3.7.6 Russia

  10.3.7.7 Poland

  10.3.7.8 Rest of Europe

10.4 Asia-Pacific

 10.4.1 Key Trends

 10.4.2 Genetic Testing Market Size & Forecast, By Technology, 2022 – 2035

 10.4.3 Genetic Testing Market Size & Forecast, By Application, 2022 – 2035

 10.4.4 Genetic Testing Market Size & Forecast, By Product, 2022 – 2035

 10.4.5 Genetic Testing Market Size & Forecast, By Channel, 2022 – 2035

 10.4.6 Genetic Testing Market Size & Forecast, By End Use, 2022 – 2035

 10.4.7 Genetic Testing Market Size & Forecast, By Country, 2022 – 2035

  10.4.7.1 China

  10.4.7.2 India

  10.4.7.3 Japan

  10.4.7.4 South Korea

  10.4.7.5 Australia

  10.4.7.6 ASEAN Countries

  10.4.7.7 Rest of Asia-Pacific

10.5 Latin America

 10.5.1 Key Trends

 10.5.2 Genetic Testing Market Size & Forecast, By Technology, 2022 – 2035

 10.5.3 Genetic Testing Market Size & Forecast, By Application, 2022 – 2035

 10.5.4 Genetic Testing Market Size & Forecast, By Product, 2022 – 2035

 10.5.5 Genetic Testing Market Size & Forecast, By Channel, 2022 – 2035

 10.5.6 Genetic Testing Market Size & Forecast, By End Use, 2022 – 2035

 10.5.7 Genetic Testing Market Size & Forecast, By Country, 2022 – 2035

  10.5.7.1 Brazil

  10.5.7.2 Argentina

  10.5.7.3 Mexico

  10.5.7.4 Colombia

  10.5.7.5 Rest of Latin America

10.6 Middle East & Africa

 10.6.1 Key Trends

 10.6.2 Genetic Testing Market Size & Forecast, By Technology, 2022 – 2035

 10.6.3 Genetic Testing Market Size & Forecast, By Application, 2022 – 2035

 10.6.4 Genetic Testing Market Size & Forecast, By Product, 2022 – 2035

 10.6.5 Genetic Testing Market Size & Forecast, By Channel, 2022 – 2035

 10.6.6 Genetic Testing Market Size & Forecast, By End Use, 2022 – 2035

 10.6.7 Genetic Testing Market Size & Forecast, By Country, 2022 – 2035

  10.6.7.1 UAE

  10.6.7.2 Saudi Arabia

  10.6.7.3 Qatar

  10.6.7.4 Egypt

  10.6.7.5 South Africa

  10.6.7.6 Rest of Middle East & Africa

11. Competitive Landscape

 11.1 Key Players' Positioning

 11.2 Competitive Developments

  11.2.1 Key Strategies Adopted (%), By Key Players, 2025

  11.2.2 Year-Wise Strategies & Development, 2021 – 2025

  11.2.3 Number Of Strategies Adopted By Key Players, 2025

 11.3 Market Share Analysis, 2025

 11.4 Product/Service & Application Benchmarking

  11.4.1 Product/Service Specifications & Features By Key Players

  11.4.2 Product/Service Heatmap By Key Players

  11.4.3 Application Heatmap By Key Players

 11.5 Industry Start-Up & Innovation Landscape

11.6 Key Company Profiles
11.6.1 Illumina, Inc.

  11.6.1.1 Company Overview & Snapshot

  11.6.1.2 Product/Service Portfolio

  11.6.1.3 Key Company Financials

  11.6.1.4 SWOT Analysis

11.6.2 Myriad Genetics, Inc.

11.6.3 Thermo Fisher Scientific Inc.

11.6.4 Natera, Inc.

11.6.5 Guardant Health, Inc.

11.6.6 Foundation Medicine, Inc. (Roche)

11.6.7 Invitae Corporation

11.6.8 23andMe Holding Co.

11.6.9 Abbott Laboratories

11.6.10 Bio-Rad Laboratories, Inc.

11.6.11 F. Hoffmann-La Roche Ltd.

11.6.12 Quest Diagnostics Incorporated

11.6.13 LabCorp (Laboratory Corporation of America)

11.6.14 Counsyl (Myriad Genetics)

11.6.15 GeneDx, Inc.

11.6.16 Color Genomics Inc.

11.6.17 Ancestry.com DNA, LLC

11.6.18 Genomic Health, Inc. (Exact Sciences)

11.6.19 Centogene AG

11.6.20 Blueprint Genetics Oy

12. Analyst Recommendations

 12.1 SNS Insider Opportunity Map

 12.2 Industry Low-Hanging Fruit Assessment

 12.3 Market Entry & Growth Strategy

 12.4 Analyst Viewpoint & Suggestions On Market Growth

13. Assumptions

14. Disclaimer

15. Appendix

 15.1 List Of Tables

 15.2 List Of Figures